SpaceX's (SPCX) Starlink reapplies for India approval of satellite network, according to Economic Times
Newsquawk Staff ·
SpaceX's (SPCX) Starlink reapplies for India approval of satellite network, according to Economic Times.
What it means
Starlink's pursuit of Indian market access has been a long-running regulatory saga, with prior applications having stalled over licensing conditions, security clearances and spectrum allocation method. The word 'reapplies' is the operative one: it implies the earlier process lapsed or was withdrawn rather than approved, and that the company judges conditions, whether domestic policy, data localisation requirements or relations with the incumbent telecoms lobby, have shifted enough to try again. Episodes of this kind tend to run through a familiar sequence: application, inter-ministerial and security review, spectrum assignment debate, then licence grant with conditions, a process that in India has historically stretched well beyond initial timelines. Satellite operators face the added question of whether spectrum is assigned administratively or by auction, a distinction domestic telecoms incumbents have contested and which has delayed comparable approvals before. SpaceX is privately held, so there is no listed equity to price the news directly; the read-through is to peers and suppliers in the satellite and launch complex rather than any single ticker. What is worth watching is whether this attempt clears the security review that has historically been the choke point, and any signal on the spectrum methodology.
- Instacart (CART) is reportedly exploring a sale, The Information reports; held talks with DoorDash (DASH) and Uber (UBER)
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease
- Kimi K3.1 Pro AI model builds GTA VI-style (TTWO) playable game demo in just 10 hours for USD 52, developer claims on X; showcases AI’s ability to generate video game experiences - UNCONFIRMED
- OpenAI expects future AI models to be capable of identifying and exploiting vulnerabilities that are currently unknown, according to a blog post
- Texas Attorney General Ken Paxton sues OpenAI and CEO Sam Altman for lying to users and harming Texans
Related headlines
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL14 hours ago
- Moonshot AI unveils 2.8tln-parameter Kimi K3.1 Pro model; says it beats Opus 5.5 and GPT-6 Astra on long-horizon coding tasks and scores top marks on SWE Marathon and agent benchmarks; pledges open weights for the 3tln-class model by November 4th15 hours ago
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS16 hours ago
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 202716 hours ago
- OpenAI reveals plans for an in-house exabyte-scale storage system16 hours ago
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter16 hours ago
- Upside in Penguin Solutions (PEGN) attributed to M&A chatter - UNCONFIRMED 16 hours ago
- CrowdStrike (CRWD) CEO says in the coming months we will see a lot of breaches from the PHP vulnerability17 hours ago
- US President Trump says Elon Musk will not do anything wrong regarding access to Starlink (SPCX) in Ukraine17 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)17 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed17 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce18 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders19 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer19 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation19 hours ago